arrow_back Back to App

Support for Sickle Cell Awareness Day: Research and Better Treatment Access

This House Resolution supports World Sickle Cell Awareness Day to boost public knowledge about the disease. It emphasizes the need for more research, early detection, and improved access to treatments, aiming to enhance the quality of life for affected individuals and their families.
Key points
Increasing public awareness about sickle cell disease and its impact on lives.
Supporting scientific research, early detection, and the development of new, effective treatments.
Striving to ensure equitable access to innovative therapies for all who need them, regardless of background.
Encouraging the organization of educational events and preventative care programs.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HRES_1176
Sponsor: Rep. Davis, Danny K. [D-IL-7]
Process start date: 2022-06-15
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Expressing support for the designation of June 19, 2022, as "World Sickle Cell Awareness Day" in order to increase public alertness across the United States and global community about sickle cell disease, the continued need for empirical research, early detection screenings for sickle cell trait carriers, novel effective treatments leading to a cure, and preventative care programs with respect to complications from sickle cell anemia and conditions related to sickle cell disease.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HRES_1176.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-06-15.

What are the main provisions?

Key points include:

  • Increasing public awareness about sickle cell disease and its impact on lives.
  • Supporting scientific research, early detection, and the development of new, effective treatments.
  • Striving to ensure equitable access to innovative therapies for all who need them, regardless of background.
  • Encouraging the organization of educational events and preventative care programs.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Davis, Danny K. [D-IL-7].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Health